OSCR Stock Analysis: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$28.40
0.13 (0.46%)
▲
5d:
-1.76%
30d:
+15.82%
90d:
+113.53%
HOLD
MODERATE Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Smart Money Distribution
None View Scanner →
Strength: 8.4/10
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: OSCR trades at premium valuation expecting 15.1% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: OSCR trades at premium valuation expecting 15.1% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$36.13
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$22.43
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $28.40, which is considered extended relative to its 30-day fair value range of $21.92 to $27.30. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.4) compared to its historical average (12.7). At these levels, the market is pricing in 15.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, OSCR is in a strong uptrend. The price is approaching resistance at $28.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OSCR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $22.60. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OSCR is in a strong uptrend. The price is approaching resistance at $28.16. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: OSCR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $22.60. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$21.92 -
$27.30
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.4%
Protect Your Profits
Holding OSCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 20.4% above Wall St target ($22.60)
- NEUTRAL: PE elevated vs history but 15.1% growth expectation is conservative given 126% recent growth
Trading Range Analysis
30-Day Trading Range
$21.92 -
$27.30
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.09
Resistance Level
$28.16
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.44
Wall Street Target
$22.60
(-20.4%)
Revenue Growth (YoY)
52.6%
Earnings Growth (YoY)
125.6%
Profit Margin
-0.3%
Valuation Premium vs History
+15.1% premium
PE vs Historical
19.4 vs 12.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+15.1%
(market-implied from PE analysis)
1-Year Target
$32.69
(+15%)
2-Year Target
$37.62
(+33%)
3-Year Target
$43.31
(+53%)
3-Yr Target (if PE normalizes)
(PE: 19→13)
PE COMPRESSION
$28.29
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 36.2%)
$80.35
(+183%)
Base:
(SPY PE: 19.4, Growth: 36.2%)
$71.73
(+153%)
Bear:
(PE: 12.7, Growth: 36.2%)
$46.85
(+65%)
Share & Embed Analysis
Last updated: June 22, 2026 3:11 AM ET
Data refreshes hourly during market hours. Next update: 4:11 AM
Data refreshes hourly during market hours. Next update: 4:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
1
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark T Bertolini
BUY
1000000 shares
2026-04-06
Mario Schlosser
SELL
23038 shares
2026-01-08
Mario Schlosser
SELL
76962 shares
2026-01-06
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$105 | 64 BUY |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$410 | 53 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$341 | 58 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$416 | 59 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$302 | 57 HOLD |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
